METACRINE Trademark

Trademark Overview

On Thursday, August 23, 2018, a trademark application was filed for METACRINE with the United States Patent and Trademark Office. The USPTO has given the METACRINE trademark a serial number of 88090309. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 31, 2022. This trademark is owned by Metacrine, Inc.. The METACRINE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the treatment of metabolic, endocrine, gastrointestinal, and liver diseases and disorders
metacrine

General Information

Serial Number88090309
Word MarkMETACRINE
Filing DateThursday, August 23, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 31, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 30, 2019

Trademark Statements

Goods and ServicesPharmaceuticals for the treatment of metabolic, endocrine, gastrointestinal, and liver diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, September 1, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMetacrine, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameMetacrine, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Monday, October 31, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 31, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 21, 2022SOU EXTENSION 5 GRANTED
Friday, March 11, 2022SOU EXTENSION 5 FILED
Monday, March 21, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, March 11, 2022TEAS EXTENSION RECEIVED
Friday, September 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 8, 2021SOU EXTENSION 4 GRANTED
Wednesday, September 8, 2021SOU EXTENSION 4 FILED
Wednesday, September 8, 2021TEAS EXTENSION RECEIVED
Tuesday, January 26, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, January 24, 2021SOU EXTENSION 3 GRANTED
Sunday, January 24, 2021SOU EXTENSION 3 FILED
Sunday, January 24, 2021TEAS EXTENSION RECEIVED
Friday, September 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 16, 2020SOU EXTENSION 2 GRANTED
Wednesday, September 16, 2020SOU EXTENSION 2 FILED
Wednesday, September 16, 2020TEAS EXTENSION RECEIVED
Thursday, February 13, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 11, 2020SOU EXTENSION 1 GRANTED
Tuesday, February 11, 2020SOU EXTENSION 1 FILED
Tuesday, February 11, 2020TEAS EXTENSION RECEIVED
Tuesday, September 24, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 30, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 30, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 10, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, June 21, 2019ASSIGNED TO LIE
Wednesday, June 12, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 12, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 12, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 12, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 13, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 13, 2018NON-FINAL ACTION E-MAILED
Thursday, December 13, 2018NON-FINAL ACTION WRITTEN
Friday, December 7, 2018ASSIGNED TO EXAMINER
Saturday, September 1, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, August 27, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

metacrine liver diseases disorders gastrointestinal endocrine treatment metabolic pharmaceuticals